CDKN1A and astrocytoma (excluding glioblastoma): Based on these data, we determined the prevalence of genetic polymorphisms of CDKN1A in a sample of 10 ependymomas, 16 medulloblastomas and 15 astrocytomas from the northwestern part of the State of São Paulo, compared with 161 control subjects.